Fundraising Fox
Interwell Health
Waltham, US · Founded 2019 · Delaware LLC · 3 known investors
Find your way into Interwell Health
Sign up to see every warm intro you have to Interwell Health
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Interwell Health team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Interwell Health provides value-based kidney care, partnering with health plans, payers, and nephrology practices to support patients through nurses and dietitians and improve patient outcomes. It works to lower total cost of care and offers educational resources for patients and industry insights for providers and payers.
Founders & leadership
GH
George HartChief Medical OfficerHe has over 30 years of experience in nephrology as a practicing physician, including roles as President of Metrolina Nephrology Associates in Charlotte, Medical Director for Fresenius Kidney Care, and Medical Director of the Kidney and Pancreas Transplant Programs at Carolinas Healthcare System; he also served as a Clinical Assistant Professor at UNC Chapel Hill and holds an MD from Wake Forest University.
KA
Karen A. GledhillExecutive Vice President2020–2023Karen Gledhill spent 24 years as a healthcare attorney at Robinson, Bradshaw in Charlotte, focusing on corporate transactions and regulatory matters, before joining Fresenius Medical Care in 2014 as General Counsel and later leading its payer relations team. She is an Executive Vice President at Interwell Health, a kidney care company formed in 2019.
AV
Alex ValleNamed on SEC filing
CT
Carney TaylorNamed on SEC filing
TB
Tracy BahlNamed on SEC filing
CZ
Charles ZachemNamed on SEC filing
GL
Gina LoftenNamed on SEC filing
AA
Alex AzarNamed on SEC filing
RS
Robert SepuchaNamed on SEC filing
JA
John ArlottaNamed on SEC filing
Investors · 3
Reported raises · per SEC filings
Form D private placements$84.4M disclosed across 3 rounds · 2019–2023
▶$18.3MraisedMar 2023 · 27 investors · Other Health CareRule 506(c)
▶$18.3MraisedMar 2023 · 27 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Alex ValleDirector
- David PollackExecutive Officer
- Carney TaylorDirector
- Tracy BahlDirector
- Charles ZachemDirector
- Gina LoftenDirector
- Alex AzarDirector
- Robert SepuchaExecutive Officer, Director
- John ArlottaDirector
- Offering amount
- $18.3M
- Amount sold
- $18.3M
- Minimum investment
- $100K
- First sale
- Mar 2023
- Incorporated
- Limited Partnership, Delaware, 2022
- Federal exemptions
- 06c
▶$46.1MraisedMay 2021 · 53 investors · Other Health CareRule 506(b)
▶$46.1MraisedMay 2021 · 53 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Susan PriceDirector
- KIm SonnenDirector
- Manish TannaDirector
- Ruben VelezDirector
- Dylan SteerDirector
- Ashish SoniDirector
- Ben HippenDirector
- George HartExecutive Officer
- Karen A. GledhillExecutive Officer, Director
- David PollackDirector
- Terry KetchersidExecutive Officer
- Eric MaaskeDirector
- Jeffrey L. HymesDirector
- William J. ValleDirector
- Offering amount
- $46.1M
- Amount sold
- $46.1M
- First sale
- Apr 2021
- Incorporated
- Limited Liability Company, Delaware, 2019
- Federal exemptions
- 06b
▶$20MraisedApr 2020 · 17 investors · Other Health CareRule 506(b)
▶$20MraisedApr 2020 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- KIm SonnenExecutive Officer
- Jeffrey L. HymesExecutive Officer
- Karen A. GledhillExecutive Officer
- David PollackExecutive Officer
- William J. ValleExecutive Officer
- Offering amount
- $20M
- Amount sold
- $20M
- Minimum investment
- $250K
- First sale
- Dec 2019
- Incorporated
- Limited Liability Company, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
KidneyThe National Kidney Foundation works to eliminate preventable kidney disease, accelerate innovation in patient care, and address structural inequities in kidney treatment and transplantation services. The organization serves patients with kidney disease and at-risk communities.
AmwellTelemedicine services for health systems, health plans, employers, and physicians
Companies working in the same space as Interwell Health.
Frequently asked questions
- What does Interwell Health do?
- Interwell Health provides value-based kidney care, partnering with health plans, payers, and nephrology practices to support patients through nurses and dietitians and improve patient outcomes. It works to lower total cost of care and offers educational resources for patients and industry insights for providers and payers.
- Who are Interwell Health's investors?
- Interwell Health's investors include BoxGroup, Oak HC/FT, Nexus Venture Partners.
- How much funding has Interwell Health raised?
- Interwell Health has disclosed $84.4M raised across 3 rounds.
- Where is Interwell Health headquartered?
- Interwell Health is headquartered in Waltham, US.